Uso de inhibidores de tirosina quinasa en carcinoma medular de tiroides. Experiencia Institucional
Luca, Romina; Tsou, Florencia; Rivero, Sergio; Flaco, Agustín; O'Conor, Juan.
Oncol. clín
; 22(1): 22-27, 2017. tab, Graf
Artículo en Español | LILACS | ID: biblio-882376
Documentos relacionados
Advances and controversies in the management of medullary thyroid carcinoma.
Medullary thyroid cancer: early detection and novel treatments.
An encapsulated oncoytic neoplasm of follicular origin of thyroid, expressing neuroendocrine markers. A case report and literature review.
Diagnostic Utility of Procalcitonin for Sporadic Medullary Thyroid Carcinoma in Patients with Nodular Disease and Mild or Moderate Hypercalcitoninemia.
Guía práctica para el manejo de efectos adversos por inhibidores multicinasas (sorafenib y vandetanib) en pacientes con cáncer de tiroides avanzado
Fine needle aspiration cytology diagnosis of renal medullary carcinoma: a case report.
A case report of simultaneous medullary and papillary carcinoma of thyroid.
Molecular targets of tyrosine kinase inhibitors in thyroid cancer.
Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma.
Diagnostic challenges of renal medullary carcinoma and the role for cytologic assessment: Case report and literature review.